Evaluation of S1RBD-Specific IgG Antibody Responses following COVID-19 Vaccination in Healthcare Professionals in Cyprus: A Comparative Look between the Vaccines of Pfizer-BioNTech and AstraZeneca

There is an ongoing effort to report data on SARS-CoV-2 antibodies in different individuals. Ninety-seven healthcare workers were enrolled in this study (Pfizer’s BNT162b2, n = 52; and AstraZeneca’s ChAdOx1-S, n = 45) and S1RBD-specific IgG antibodies were analyzed over time. Both vaccines induced S...

Descripción completa

Detalles Bibliográficos
Autores principales: Deeba, Elie, Krashias, George, Constantinou, Astero, Koptides, Dana, Lambrianides, Anastasia, Christodoulou, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147250/
https://www.ncbi.nlm.nih.gov/pubmed/35630412
http://dx.doi.org/10.3390/microorganisms10050967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147250/
https://www.ncbi.nlm.nih.gov/pubmed/35630412
http://dx.doi.org/10.3390/microorganisms10050967

Ejemplares similares